v2.4.0.8

Segments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2013
Segment Reporting Information [Line Items] |
Segment Reporting Disclosure [Text Block] | Segments Beginning with the acquisition of MTS in May, 2012, we have organized our business into two operating business segments: Acute Care, which primarily includes products and services sold to hospital customers and Non-Acute Care, which primarily includes products and services sold to customers outside of hospital settings. The Acute Care segment is organized around the design, manufacturing, selling and servicing of medication and supply dispensing systems. The Non-Acute Care segment includes primarily the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services, but also includes medication dispensing systems sold to non-acute care pharmacies and facilities. We report segment information based on the management approach. The management approach designates the internal reporting used by the Chief Operating Decision Maker (the "CODM") for making decisions and assessing performance as the source of our operating segments. The CODM is our Chief Executive Officer. The CODM allocates resources to and assesses the performance of each operating segment, using information about its revenues, gross profit and income (loss) from operations. Since 1992, Omnicell has provided automation and business information solutions to acute care hospitals. We have developed product solutions that help optimize various workflows utilized in hospitals. We have also developed sophisticated sales, installation, and service capabilities to serve the specific and special needs of the acute care environment in hospitals. As the acute care market evolves, we see opportunities to provide medication adherence solutions, which were added to our product line through the acquisition of MTS. A portion of our organization structure and management processes will continue to be structured to optimize sales and service of solutions to the acute care market. Since 1984, MTS has provided medication adherence solutions to the non-acute care market. These solutions provide automated and semi-automated equipment to assist institutional and retail pharmacists in filling medication orders into blister cards, the primary method of medication control in non-acute care settings. Completing the product solution are the consumables used by institutional and retail pharmacists to make the medication adherence package. MTS has developed process manufacturing capabilities as well as sales capabilities to market medication adherence solutions to institutional and retail pharmacies. A portion of our organization structure and management processes will continue to be structured to optimize the product, sales, and service of solutions to the non-acute care market. During 2012, we realigned our management reporting structure to report sales of Omnicell's dispensing systems and other related business transactions to long-term care pharmacies and facilities. Accordingly, the operations of this portion of our activities are now being reflected as a part of the Non-Acute Care segment for three and nine months ended September 30, 2013. We believe that legislative changes and economic pressures to manage costs will cause healthcare organizations to manage the health of patients across the continuum of care regardless of the setting in which the care is provided. We believe we have the capabilities and market position to provide the tools needed by our customers to manage medications across the continuum of care. But we also believe that the inherent differences between medication management workflows in acute care settings and non-acute care settings will cause our product solutions and marketing strategies to be managed separately for these two customer segments. Effective in the second quarter of 2013, our management changed its methodology for allocating certain expenses to our reportable segments. We have reclassified segment operating results for the three and nine months ended September 30, 2012 to conform to the 2013 presentation. For the three and nine months ended September 30, 2013 and 2012, the contributions of our segments to net revenues and income from operations, and the reconciliation to total net income, were as follows (amounts in thousands):
| Three Months Ended September 30, 2013 |  | Three Months Ended September 30, 2012
| Acute Care |  | Non-Acute Care |  | Total |  | Acute Care |  | Non-Acute Care (1) |  | Total
Net revenues from external customers | $ | 70,640 |  |  | $ | 23,399 |  |  | $ | 94,039 |  |  | $ | 64,394 |  |  | 19,937 |  |  | $ | 84,331 |
Cost of revenues | 28,662 |  |  | 13,337 |  |  | 41,999 |  |  | 26,920 |  |  | 11,324 |  |  | 38,244 |
Gross profit | $ | 41,978 |  |  | $ | 10,062 |  |  | $ | 52,040 |  |  | $ | 37,474 |  |  | $ | 8,613 |  |  | $ | 46,087 |
Gross margin % | 59.4 | % |  | 43.0 | % |  | 55.3 | % |  | 58.2 | % |  | 43.2 | % |  | 54.7 | %
Operating expenses | 32,908 |  |  | 8,415 |  |  | 41,323 |  |  | 29,070 |  |  | 5,791 |  |  | 34,861 |
Income from operations | $ | 9,070 |  |  | $ | 1,647 |  |  | $ | 10,717 |  |  | $ | 8,404 |  |  | 2,822 |  |  | $ | 11,226 |
Operating margin % | 12.8 | % |  | 7.0 | % |  | 11.4 | % |  | 13.1 | % |  | 14.2 | % |  | 13.3 | %
Interest and other income (expense), net |  |  |  |  | 25 |  |  |  |  |  |  | 34 |
Income before provision for income taxes |  |  |  |  | 10,742 |  |  |  |  |  |  | 11,260 |
Provision for income taxes |  |  |  |  | 2,987 |  |  |  |  |  |  | 4,340 |
Net income |  |  |  |  | $ | 7,755 |  |  |  |  |  |  | $ | 6,920 |
(1) Non-Acute Care segment includes MTS results from May 21, 2012, the date of acquisition.
| Nine Months Ended September 30, 2013 |  | Nine Months Ended September 30, 2012
| Acute Care |  | Non-Acute Care |  | Total |  | Acute Care |  | Non-Acute Care (1) |  | Total
Net revenues from external customers | $ | 204,750 |  |  | $ | 70,085 |  |  | $ | 274,835 |  |  | $ | 191,295 |  |  | $ | 32,563 |  |  | $ | 223,858 |
Cost of revenues | 87,784 |  |  | 40,276 |  |  | 128,060 |  |  | 82,859 |  |  | 19,787 |  |  | 102,646 |
Gross profit | $ | 116,966 |  |  | $ | 29,809 |  |  | $ | 146,775 |  |  | $ | 108,436 |  |  | $ | 12,776 |  |  | $ | 121,212 |
Gross margin % | 57.1 | % |  | 42.5 | % |  | 53.4 | % |  | 56.7 | % |  | 39.2 | % |  | 54.1 | %
Operating expenses | 96,048 |  |  | 26,483 |  |  | 122,531 |  |  | 94,167 |  |  | 9,753 |  |  | 103,920 |
Income from operations | $ | 20,918 |  |  | $ | 3,326 |  |  | $ | 24,244 |  |  | $ | 14,269 |  |  | 3,023 |  |  | $ | 17,292 |
Operating margin % | 10.2 | % |  | 4.7 | % |  | 8.8 | % |  | 7.5 | % |  | 9.3 | % |  | 7.7 | %
Interest and other income (expense), net |  |  |  |  | (134 | ) |  |  |  |  |  | 57 |
Income before provision for income taxes |  |  |  |  | 24,110 |  |  |  |  |  |  | 17,349 |
Provision for income taxes |  |  |  |  | 6,954 |  |  |  |  |  |  | 6,703 |
Net income |  |  |  |  | $ | 17,156 |  |  |  |  |  |  | $ | 10,646 |
(1) Non-Acute Care segment includes MTS results from May 21, 2012, the date of acquisition.
At September 30, 2013, segment assets were as follows (amounts in thousands):
| September 30, 2013 |  | December 31, 2012
| Acute Care |  | Non-Acute Care |  | Total |  | Acute Care |  | Non-Acute Care (1) |  | Total
Segment Assets | $ | 284,067 |  |  | $ | 221,917 |  |  | $ | 505,984 |  |  | $ | 235,186 |  |  | $ | 206,633 |  |  | $ | 441,819 |
At three and nine months ended September 30, 2013 and 2012, segment depreciation/amortization, and capital expenditures were as follows (amounts in thousands):
| Three Months Ended September 30, 2013 |  | Three Months Ended September 30, 2012
| Acute Care |  | Non-Acute Care |  | Total |  | Acute Care |  | Non-Acute Care (1) | Total
Depreciation/Amortization | $ | 2,805 |  |  | $ | 1,683 |  |  | $ | 4,488 |  |  | $ | 2,072 |  |  | $ | 1,842 |  | $ | 3,914 |
Capital Expenditures | 1,311 |  |  | 745 |  |  | 2,056 |  |  | $ | 4,940 |  |  | $ | 532 |  | $ | 5,472 |
(1) Non-Acute Care segment includes MTS results from May 21, 2012, the date of acquisition. |
| Nine Months Ended September 30, 2013 |  | Nine Months Ended September 30, 2012
| Acute Care |  | Non-Acute Care |  | Total |  | Acute Care |  | Non-Acute Care (1) | Total
Depreciation/Amortization | $ | 8,351 |  |  | $ | 5,381 |  |  | $ | 13,732 |  |  | $ | 6,538 |  |  | $ | 2,709 |  | 9,247 |
Capital Expenditures | 3,329 |  |  | 4,478 |  |  | 7,807 |  |  | $ | 8,947 |  |  | $ | 612 |  | $ | 9,559 |
(1) Non-Acute Care segment includes MTS results from May 21, 2012, the date of acquisition. |
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] | For the three and nine months ended September 30, 2013 and 2012, the contributions of our segments to net revenues and income from operations, and the reconciliation to total net income, were as follows (amounts in thousands):
| Three Months Ended September 30, 2013 |  | Three Months Ended September 30, 2012
| Acute Care |  | Non-Acute Care |  | Total |  | Acute Care |  | Non-Acute Care (1) |  | Total
Net revenues from external customers | $ | 70,640 |  |  | $ | 23,399 |  |  | $ | 94,039 |  |  | $ | 64,394 |  |  | 19,937 |  |  | $ | 84,331 |
Cost of revenues | 28,662 |  |  | 13,337 |  |  | 41,999 |  |  | 26,920 |  |  | 11,324 |  |  | 38,244 |
Gross profit | $ | 41,978 |  |  | $ | 10,062 |  |  | $ | 52,040 |  |  | $ | 37,474 |  |  | $ | 8,613 |  |  | $ | 46,087 |
Gross margin % | 59.4 | % |  | 43.0 | % |  | 55.3 | % |  | 58.2 | % |  | 43.2 | % |  | 54.7 | %
Operating expenses | 32,908 |  |  | 8,415 |  |  | 41,323 |  |  | 29,070 |  |  | 5,791 |  |  | 34,861 |
Income from operations | $ | 9,070 |  |  | $ | 1,647 |  |  | $ | 10,717 |  |  | $ | 8,404 |  |  | 2,822 |  |  | $ | 11,226 |
Operating margin % | 12.8 | % |  | 7.0 | % |  | 11.4 | % |  | 13.1 | % |  | 14.2 | % |  | 13.3 | %
Interest and other income (expense), net |  |  |  |  | 25 |  |  |  |  |  |  | 34 |
Income before provision for income taxes |  |  |  |  | 10,742 |  |  |  |  |  |  | 11,260 |
Provision for income taxes |  |  |  |  | 2,987 |  |  |  |  |  |  | 4,340 |
Net income |  |  |  |  | $ | 7,755 |  |  |  |  |  |  | $ | 6,920 |
(1) Non-Acute Care segment includes MTS results from May 21, 2012, the date of acquisition.
Schedule of Segment Reporting Information, by Segment [Table Text Block] | At September 30, 2013, segment assets were as follows (amounts in thousands):
| September 30, 2013 |  | December 31, 2012
| Acute Care |  | Non-Acute Care |  | Total |  | Acute Care |  | Non-Acute Care (1) |  | Total
Segment Assets | $ | 284,067 |  |  | $ | 221,917 |  |  | $ | 505,984 |  |  | $ | 235,186 |  |  | $ | 206,633 |  |  | $ | 441,819 |
At three and nine months ended September 30, 2013 and 2012, segment depreciation/amortization, and capital expenditures were as follows (amounts in thousands):
| Three Months Ended September 30, 2013 |  | Three Months Ended September 30, 2012
| Acute Care |  | Non-Acute Care |  | Total |  | Acute Care |  | Non-Acute Care (1) | Total
Depreciation/Amortization | $ | 2,805 |  |  | $ | 1,683 |  |  | $ | 4,488 |  |  | $ | 2,072 |  |  | $ | 1,842 |  | $ | 3,914 |
Capital Expenditures | 1,311 |  |  | 745 |  |  | 2,056 |  |  | $ | 4,940 |  |  | $ | 532 |  | $ | 5,472 |
(1) Non-Acute Care segment includes MTS results from May 21, 2012, the date of acquisition. |
| Nine Months Ended September 30, 2013 |  | Nine Months Ended September 30, 2012
| Acute Care |  | Non-Acute Care |  | Total |  | Acute Care |  | Non-Acute Care (1) | Total
Depreciation/Amortization | $ | 8,351 |  |  | $ | 5,381 |  |  | $ | 13,732 |  |  | $ | 6,538 |  |  | $ | 2,709 |  | 9,247 |
Capital Expenditures | 3,329 |  |  | 4,478 |  |  | 7,807 |  |  | $ | 8,947 |  |  | $ | 612 |  | $ | 9,559 |
(1) Non-Acute Care segment includes MTS results from May 21, 2012, the date of acquisition. |

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, and discontinued operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -Paragraph 32 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8736-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8813-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -Paragraph 27, 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration